Literature DB >> 8886395

The role of ketoconazole in the QTc interval prolonging effects of H1-antihistamines in a guinea-pig model of arrhythmogenicity.

J Gras1, J Llenas, J M Palacios, D J Roberts.   

Abstract

We have carried out experiments to re-evaluate the influence of ketoconazole (400 mg kg-1,p.o.) on the effects of ebastine, terfenadine and loratadine on the QTc interval in conscious guinea-pigs. Following a previously described protocol of oral drug administration, but using telemetric recording of the ECG, we have found that the prolongation of the QTc interval attributed to ebastine and terfenadine is in fact entirely due to ketoconazole, and that neither terfenadine, ebastine nor loratadine produce any additional effects on subsequent administration.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8886395      PMCID: PMC1915872          DOI: 10.1111/j.1476-5381.1996.tb15968.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  7 in total

1.  From the Food and Drug Administration.

Authors:  S L Nightingale
Journal:  JAMA       Date:  1992-08-12       Impact factor: 56.272

2.  Analysis of serial measurements in medical research.

Authors:  J N Matthews; D G Altman; M J Campbell; P Royston
Journal:  BMJ       Date:  1990-01-27

3.  Cardiotoxic and drug interaction profile of the second generation antihistamines ebastine and terfenadine in an experimental animal model of torsade de pointes.

Authors:  J A Hey; M del Prado; W Kreutner; R W Egan
Journal:  Arzneimittelforschung       Date:  1996-02

4.  Blockade of multiple human cardiac potassium currents by the antihistamine terfenadine: possible mechanism for terfenadine-associated cardiotoxicity.

Authors:  W J Crumb; B Wible; D J Arnold; J P Payne; A M Brown
Journal:  Mol Pharmacol       Date:  1995-01       Impact factor: 4.436

5.  Terfenadine-ketoconazole interaction. Pharmacokinetic and electrocardiographic consequences.

Authors:  P K Honig; D C Wortham; K Zamani; D P Conner; J C Mullin; L R Cantilena
Journal:  JAMA       Date:  1993 Mar 24-31       Impact factor: 56.272

6.  Effects of terfenadine and its metabolites on a delayed rectifier K+ channel cloned from human heart.

Authors:  D Rampe; B Wible; A M Brown; R C Dage
Journal:  Mol Pharmacol       Date:  1993-12       Impact factor: 4.436

7.  Torsades de pointes occurring in association with terfenadine use.

Authors:  B P Monahan; C L Ferguson; E S Killeavy; B K Lloyd; J Troy; L R Cantilena
Journal:  JAMA       Date:  1990-12-05       Impact factor: 56.272

  7 in total
  7 in total

Review 1.  Effects of H1 antihistamines on animal models of QTc prolongation.

Authors:  J Gras; J Llenas
Journal:  Drug Saf       Date:  1999       Impact factor: 5.606

Review 2.  Assessing the cardiac safety of ebastine. Prologue.

Authors:  D J Roberts
Journal:  Drug Saf       Date:  1999       Impact factor: 5.606

Review 3.  Assessing the cardiac safety of ebastine. Epilogue.

Authors:  D J Roberts
Journal:  Drug Saf       Date:  1999       Impact factor: 5.606

4.  Cardiotoxicity of second-generation antihistamines.

Authors:  D J Roberts
Journal:  Drugs       Date:  1999-06       Impact factor: 9.546

5.  Computer-assisted comparison of the structural and electronic dispositions of ebastine and terfenadine.

Authors:  V Segarra; M López; H Ryder; J M Palacios; D J Roberts
Journal:  Drug Saf       Date:  1999       Impact factor: 5.606

Review 6.  Second-generation antihistamines: actions and efficacy in the management of allergic disorders.

Authors:  Larry K Golightly; Leon S Greos
Journal:  Drugs       Date:  2005       Impact factor: 9.546

7.  Ebastine in the light of CONGA recommendations for the development of third-generation antihistamines.

Authors:  S Rico; Rm Antonijoan; Mj Barbanoj
Journal:  J Asthma Allergy       Date:  2009-08-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.